Cel-Sci
CVM
#9791
Rank
ยฃ35.63 M
Marketcap
ยฃ4.24
Share price
-1.19%
Change (1 day)
-55.47%
Change (1 year)

Cel-Sci (CVM) - Total debt

Total debt on the balance sheet as of September 2025 : ยฃ6.85 Million

According to Cel-Sci 's latest financial reports the company's total debt is ยฃ6.85 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Cel-Sci - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2025-09-30ยฃ6.98 M-19.66%
2024-09-30ยฃ8.68 M-21.92%
2023-09-30ยฃ11.12 M-19.09%
2022-09-30ยฃ13.75 M15.98%
2021-09-30ยฃ11.85 M9.9%
2020-09-30ยฃ10.78 M-1.83%
2019-09-30ยฃ10.99 M7.11%
2018-09-30ยฃ10.26 M-3.23%
2017-09-30ยฃ10.6 M5.64%
2016-09-30ยฃ10.03 M9.32%
2015-09-30ยฃ9.18 M1227.41%
2014-09-30ยฃ0.69 M-1.19%
2013-09-30ยฃ0.7 M2.25%
2012-09-30ยฃ0.68 M-78.61%
2011-09-30ยฃ3.2 M355.65%
2010-09-30ยฃ0.7 M0.88%
2009-09-30ยฃ0.69 M516.25%
2008-09-30ยฃ0.11 M
2005-09-30ยฃ0 M2.14%
2004-09-30ยฃ0 M-99.68%
2003-09-30ยฃ0.52 M-53.93%
2002-09-30ยฃ1.13 M5262.83%
2001-09-30ยฃ0.02 M25.45%
2000-09-30ยฃ0.01 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
ยฃ33.46 B 487,916.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ39.88 B 581,609.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
ยฃ50.61 M 638.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
ยฃ1.43 M-79.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ12.47 B 181,839.28%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
ยฃ0.47 B 6,777.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.48 B 6,966.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
ยฃ0.4 M-94.12%๐Ÿ‡บ๐Ÿ‡ธ USA